877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

trc-canada.com, PDE4 inhibitors

Categories

Antiasthmatic drugs (5)
Drugs acting on the respiratory system (5)
Respiratory agents (5)
Pharmaceuticals (4)
Drugs acting on the nervous system (2)
Ketones (2)
Psychoactive drugs (2)
Xanthines (2)
Acids (1)
Carboxylic acids (1)
Cyclic compounds (1)
Cycloalkanes (1)
Cyclopropanes (1)
Drugs acting on the cardiovascular system (1)
Halides (1)
Organic acids (1)
Organofluorides (1)
Organohalides (1)
Three-membered rings (1)
Vasodilators (1)

Suppliers

AK Scientific (4)
Sigma Aldrich (3)
Matrix Scientific (2)
TCI Chemicals (2)
Frontier Scientific (1)
Oakwood Chemical (1)

Roflumilast (162401-32-3)  
Roflumilast (trade names Daxas, Daliresp) is a drug that acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4). It has anti-inflammatory effects and is used as an orally administered drug for the treatment of inflammatory conditions of the lungs such as chronic obstructive pulmonary disease (COPD). In June 2010, it was approved in the EU for severe COPD associated with chronic bronchitis.
pentoxifylline (6493-05-6)  
Trental  ·  Torental  ·  Pentoxil
Pentoxifylline, also known as oxpentifylline, is a xanthine derivative used as a drug to treat muscle pain in people with peripheral artery disease. It is generic and sold under many brand names worldwide.
luteolin (491-70-3)  
Luteoline  ·  3',4',5,7-Tetrahydroxy-Flavone  ·  3',4',5,7-Tetrahydroxyflavone
Luteolin is a flavone, a type of flavonoid, with a yellow crystalline appearance.
propentofylline (55242-55-2)  
HWA 285  ·  1-(5'-oxohexyl)-3-methyl-7-propylxanthine  ·  HWA-285
Propentofylline (HWA 285) is a xanthine derivative with purported neuroprotective effects.
Cilomilast (153259-65-5)  
Cilomilast (INN, codenamed SB-207,499, proposed trade name Ariflo) is a drug which was developed for the treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). It is orally active and acts as a selective phosphodiesterase-4 inhibitor. Phosphodiesterase (PDE) inhibitors, such as theophylline, have been used to treat COPD for centuries; however, the clinical benefits of these agents have never been shown to outweigh the risks of their numerous adverse effects.
Related searches
trc-canada.com
PDE4 inhibitors